2019
Smoking and Helicobacter pylori infection
Ferro A, Morais S, Pelucchi C, Aragonés N, Kogevinas M, López-Carrillo L, Malekzadeh R, Tsugane S, Hamada GS, Hidaka A, Hernández-Ramírez RU, López-Cervantes M, Zaridze D, Maximovitch D, Pourfarzi F, Zhang ZF, Yu GP, Pakseresht M, Ye W, Plymoth A, Leja M, Gasenko E, Derakhshan MH, Negri E, La Vecchia C, Peleteiro B, Lunet N. Smoking and Helicobacter pylori infection. European Journal Of Cancer Prevention 2019, Publish Ahead of Print: &na;. PMID: 30272597, DOI: 10.1097/cej.0000000000000471.Peer-Reviewed Original ResearchConceptsH. pylori seropositivityHelicobacter pylori infectionPylori infectionPylori seropositivityPrevalence ratiosStomach cancer Pooling (StoP) ProjectDuration of smokingH. pylori infectionCase-control studyConfidence intervalsSummary odds ratiosIndividual participant dataOdds ratioEgger's testGastric cancerStratified analysisMajor covariatesPooling ProjectGreater prevalenceSmokingH. pyloriSignificant associationPublication biasSeropositivityInfectionSex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project)
Ferro A, Morais S, Pelucchi C, Dierssen-Sotos T, Martín V, López-Carrillo L, Malekzadeh R, Tsugane S, Hamada GS, Hidaka A, Hernández-Ramírez RU, López-Cervantes M, Zaridze D, Maximovitch D, Pourfarzi F, Zhang ZF, Yu GP, Pakseresht M, Ye W, Plymoth A, Leja M, Gasenko E, Derakhshan MH, Negri E, La Vecchia C, Peleteiro B, Lunet N. Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project). European Journal Of Gastroenterology & Hepatology 2019, 31: 593-598. PMID: 30839435, DOI: 10.1097/meg.0000000000001389.Peer-Reviewed Original ResearchConceptsH. pylori infectionHelicobacter pylori infectionPylori infectionPrevalence ratiosOdds ratioGastric atrophyIgG serum antibody titersStomach cancer Pooling (StoP) ProjectPublication biasInfection statusSerum antibody titersConfidence intervalsSummary odds ratiosSerum pepsinogen levelsIndividual participant dataLifetime infectionsMultiplex serologyAntibody titersHistological examinationPooling ProjectPepsinogen levelsOlder controlsInfectionParticipant dataStrong associationEducation and gastric cancer risk—An individual participant data meta‐analysis in the StoP project consortium
Rota M, Alicandro G, Pelucchi C, Bonzi R, Bertuccio P, Hu J, Zhang Z, Johnson KC, Palli D, Ferraroni M, Yu G, Galeone C, López‐Carrillo L, Muscat J, Lunet N, Ferro A, Ye W, Plymoth A, Malekzadeh R, Zaridze D, Maximovitch D, Kogevinas M, de Larrea N, Vioque J, Navarrete‐Muñoz E, Tsugane S, Hamada GS, Hidaka A, Pakseresht M, Wolk A, Håkansson N, Hernández‐Ramírez R, López‐Cervantes M, Ward M, Pourfarzi F, Mu L, Kurtz RC, Lagiou A, Lagiou P, Boffetta P, Boccia S, Negri E, La Vecchia C. Education and gastric cancer risk—An individual participant data meta‐analysis in the StoP project consortium. International Journal Of Cancer 2019, 146: 671-681. PMID: 30919464, DOI: 10.1002/ijc.32298.Peer-Reviewed Original ResearchConceptsGastric cancer riskIndividual participant dataOdds ratioCancer riskSocioeconomic positionHighest household income categoryStomach cancer Pooling (StoP) ProjectStudy-specific odds ratiosH. pylori-negative subjectsGC riskParticipant dataPylori-negative subjectsStrong risk factorRandom-effects meta-analytic modelConfidence intervalsPooled odds ratioStrong inverse associationLow socioeconomic positionPublic health interventionsHousehold income categoryNegative subjectsInverse associationRisk factorsPooling ProjectPremature mortalityAssociation of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study
Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Achenbach CJ, Hessol NA, D'Souza G, Gebo KA, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Park LS, Rabkin CS, Salters K, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R, AIDS N, Betts A, Brooks J, Freeman A, Van Rompaey S, Burchell A, Yip B, You B, Hogan B, Grasso C, Hogg R, Benson C, Drozd D, Sterling T, Haas D, Humes E, Crane H, Willig J, Eron J, Martin J, Saag M, Jing J, Zhang J, Lindsay J, Hunter-Mellado R, Deeks S, Zhu J, Montaner J, McReynolds J, Gabler K, Buchacz K, Rodriguez B, Thorne J, Margolick J, Anastos K, Jacobson L, Klein M, Kroch A, Morton L, Turner M, Fiellin D, Gange S, Mugavero M, Harrigan P, Rebeiro P, Bosch R, Kirk G, Mayer K, McKaig R, Coburn S, Napravnik S, Kitahata M, Lober W, Lee J. Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study. The Lancet HIV 2019, 6: e240-e249. PMID: 30826282, PMCID: PMC6531288, DOI: 10.1016/s2352-3018(18)30360-6.Peer-Reviewed Original ResearchConceptsNon-Hodgkin lymphomaRecent CD4 countCD4 countHIV viraemiaKey independent predictorsViral loadIndependent predictorsNorth American AIDS Cohort CollaborationCNS non-Hodgkin's lymphomaOverall non-Hodgkin lymphomaDiffuse large B-cell lymphomaLarge B-cell lymphomaAssociation of immunosuppressionMulticentre cohort studyNon-Hodgkin lymphoma (NHL) riskAverage viral loadUS Health ResourcesB-cell lymphomaOverall immune functionB cell activationLong-term careCohort CollaborationRecent immunosuppressionAntiretroviral therapyCohort study
2016
Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS
Park LS, Hernández-Ramírez RU, Silverberg MJ, Crothers K, Dubrow R. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS. AIDS 2016, 30: 273-291. PMID: 26691548, PMCID: PMC4689318, DOI: 10.1097/qad.0000000000000922.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHigh-risk HPV infectionCancer risk factorsHepatitis B virusHepatitis C virusUS adultsHPV infectionRisk factorsHIV/AIDSPrevalence estimatesHuman papillomavirusAnal high-risk HPV infectionCervical high-risk HPV infectionOral high-risk HPV infectionModifiable cancer risk factorsOverweight/obesity prevalenceConsiderable study heterogeneityChronic HCV infectionOverweight/obesityPrevalence of smokingSummary prevalence estimatesBurden of cancerOncogenic virus infectionWestern high-income countriesAdult PLWHAAlcohol consumption prevalence